Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12
Closed -$540 1864
2025
Q4
$540 Sell
12
-11
-48% -$509 ﹤0.01% 1204
2025
Q3
$1.03K Hold
23
﹤0.01% 1124
2025
Q2
$1.1K Buy
+23
New +$1K ﹤0.01% 1082
2022
Q1
Sell
-99
Closed -$6K 984
2021
Q4
$6K Buy
+99
New +$5.68K ﹤0.01% 727

Other funds holding QGEN

CVA Family Office's QGEN Position: Q1 2026 in Review

CVA Family Office sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 12 shares — an estimated $540 sold.

CVA Family Office first reported a position in QGEN in Q4 2021 and held it in 4 quarters. The position peaked at $6K in Q4 2021. 346 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • CVA Family Office reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
  • CVA Family Office sold 12 Qiagen shares in Q1 2026, an estimated $540.
  • CVA Family Office first reported a position in Qiagen in Q4 2021 and held it in 4 quarters.
  • CVA Family Office's Qiagen position peaked at $6K in Q4 2021.
  • 346 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.